Triple-negative breast cancer (TNBC) is an aggressive subtype lacking the expression of estrogen receptor (ER), progesterone receptor (PR), and epidermal growth factor receptor type 2 (HER2) (1, 2). This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.